IDH-mutant gliomas exhibit a CpG island methylator phenotype (G-CIMP), reprogramming transcriptional networks and attenuating interferon signaling, whereas H3K27M-mutant tumors show extensive chromatin alterations, reinforcing immune exclusion (26). Here, IDH1 is linked to central nervous system cancer.